SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

_________________________________________________

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): February 7, 2013

 

Palomar Medical Technologies, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

(State or other jurisdic-

tion of incorporation)

1-11177

(Commission

File Number)

04-3128178

(IRS Employer

Identification Number)

15 Network Drive, Burlington, Massachusetts 01803

(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code (781) 993-2300

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 

On February 7, 2013, Palomar Medical Technologies, Inc. issued a press release announcing earnings for the fourth quarter and year ended December 31, 2012. A copy of the press release is attached hereto as Exhibit 99.1. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under Securities Act of 1933, as amended, or the Exchange Act, except, as shall be expressly set forth by specific reference in such a filing.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

(c) Exhibits

Number

Title

99.1

Press Release dated February 7, 2013 entitled "PALOMAR MEDICAL REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR 2012 Fourth Quarter Net Income of $2.3 Million or $0.12 per Diluted Share"


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

PALOMAR MEDICAL TECHNOLOGIES, INC.

By: /s/ Joseph P. Caruso

——————————————

President, Chief Executive Officer, and Chairman of the Board of Directors

Date: February 7, 2013

EXHIBIT INDEX